Exportar registro bibliográfico


Metrics:

Resting spontaneous baroreflex sensitivity and cardiac autonomic control in anabolic androgenic steroid users (2018)

  • Authors:
  • USP affiliated authors: YONAMINE, MAURÍCIO - FCF ; NEGRÃO, CARLOS EDUARDO - EEFE
  • Unidades: FCF; EEFE
  • DOI: 10.6061/clinics/2018/e226
  • Subjects: SISTEMA NERVOSO AUTÔNOMO; PRESSÃO SANGUÍNEA; BARORREFLEXO
  • Agências de fomento:
  • Language: Inglês
  • Imprenta:
  • Source:
    • Título do periódico: Clinics
    • ISSN: 1807-5932
    • Volume/Número/Paginação/Ano: v. 73, e226, 5 p., 2018
  • Online source accessDOI
    Informações sobre o DOI: 10.6061/clinics/2018/e226 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: gold
    • Licença: cc-by

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SANTOS, Marcelo R. dos; SOUZA, Francis R. de; TOSCHI-DIAS, Edgar; et al. Resting spontaneous baroreflex sensitivity and cardiac autonomic control in anabolic androgenic steroid users. Clinics, São Paulo, v. 73, p. 5 , 2018. Disponível em: < http://dx.doi.org/10.6061/clinics/2018/e226 > DOI: 10.6061/clinics/2018/e226.
    • APA

      Santos, M. R. dos, Souza, F. R. de, Toschi-Dias, E., Bortolotto, L. A., Yonamine, M., Negrão, C. E., et al. (2018). Resting spontaneous baroreflex sensitivity and cardiac autonomic control in anabolic androgenic steroid users. Clinics, 73, 5 . doi:10.6061/clinics/2018/e226
    • NLM

      Santos MR dos, Souza FR de, Toschi-Dias E, Bortolotto LA, Yonamine M, Negrão CE, Alves M-JNN, Costa-Hong V, Sayegh ALC, Armani R. Resting spontaneous baroreflex sensitivity and cardiac autonomic control in anabolic androgenic steroid users [Internet]. Clinics. 2018 ; 73 5 .Available from: http://dx.doi.org/10.6061/clinics/2018/e226
    • Vancouver

      Santos MR dos, Souza FR de, Toschi-Dias E, Bortolotto LA, Yonamine M, Negrão CE, Alves M-JNN, Costa-Hong V, Sayegh ALC, Armani R. Resting spontaneous baroreflex sensitivity and cardiac autonomic control in anabolic androgenic steroid users [Internet]. Clinics. 2018 ; 73 5 .Available from: http://dx.doi.org/10.6061/clinics/2018/e226

    Referências citadas na obra
    1. Achar S, Rostamian A, Narayan SM. Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm. Am J Cardiol. 2010;106((6)):893–901. http://dx.doi.org/10.1016/j.amjcard.2010.05.013 [PMC free article] [PubMed]
    2. Alves MJ, Dos Santos MR, Dias RG, Akiho CA, Laterza MC, Rondon MU, et al. Abnormal neurovascular control in anabolic androgenic steroids users. Med Sci Sports Exerc. 2010;42((5)):865–71. http://dx.doi.org/10.1249/MSS.0b013e3181c07b74 [PubMed]
    3. Lane HA, Grace F, Smith JC, Morris K, Cockcroft J, Scanlon MF, et al. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest. 2006;36((7)):483–8. http://dx.doi.org/10.1111/j.1365-2362.2006.01667.x [PubMed]
    4. Lage SG, Polak JF, O'Leary DH, Creager MA. Relationship of arterial compliance to baroreflex function in hypertensive patients. Am J Physiol. 1993;265((1 Pt 2)):H232–7. http://dx.doi.org/10.1152/ajpheart.1993.265.1.H232 [PubMed]
    5. La Rovere MT, Pinna GD, Raczak G. Baroreflex sensitivity: measurement and clinical implications. Ann Noninvasive Electrocardiol. 2008;13((2)):191–207. http://dx.doi.org/10.1111/j.1542-474X.2008.00219.x [PubMed]
    6. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension. 1998;31((1)):68–72. http://dx.doi.org/10.1161/01.HYP.31.1.68 [PubMed]
    7. Beutel A, Bergamaschi CT, Campos RR. Effects of chronic anabolic steroid treatment on tonic and reflex cardiovascular control in male rats. J Steroid Biochem Mol Biol. 2005;93((1)):43–8. http://dx.doi.org/10.1016/j.jsbmb.2004.11.003 [PubMed]
    8. Marques NetoSR, da H Silva A, dos Santos MC, Ferraz EF, Nascimento JH. The blockade of angiotensin AT1 and aldosterone receptors protects rats from synthetic androgen-induced cardiac autonomic dysfunction. Acta Physiol. 2013;208((2)):166–71. http://dx.doi.org/10.1111/apha.12056 [PubMed]
    9. Pereira-Junior PP, Chaves EA, Costa E-Sousa RH, Masuda MO, de Carvalho AC, Nascimento JH. Cardiac autonomic dysfunction in rats chronically treated with anabolic steroid. Eur J Appl Physiol. 2006;96((5)):487–94. http://dx.doi.org/10.1007/s00421-005-0111-7 [PubMed]
    10. Robertson RJ, Goss FL, Rutkowski J, Lenz B, Dixon C, Timmer J, et al. Concurrent validation of the OMNI perceived exertion scale for resistance exercise. Med Sci Sports Exerc. 2003;35((2)):333–41. http://dx.doi.org/10.1249/01.MSS.0000048831.15016.2A [PubMed]
    11. Parati G, Di Rienzo M, Mancia G. How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertens. 2000;18((1)):7–19. http://dx.doi.org/10.1097/00004872-200018010-00003 [PubMed]
    12. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation. 1991;84((2)):482–92. http://dx.doi.org/10.1161/01.CIR.84.2.482 [PubMed]
    13. Montano N, Ruscone TG, Porta A, Lombardi F, Pagani M, Malliani A. Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation. 1994;90((4)):1826–31. http://dx.doi.org/10.1161/01.CIR.90.4.1826 [PubMed]
    14. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension. 1995;26((3)):485–90. http://dx.doi.org/10.1161/01.HYP.26.3.485 [PubMed]
    15. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27((21)):2588–605. http://dx.doi.org/10.1093/eurheartj/ehl254 [PubMed]
    16. Rowe JW. Clinical consequences of age-related impairments in vascular compliance. Am J Cardiol. 1987;60((12)):68G–71G. http://dx.doi.org/10.1016/0002-9149(87)90594-7 [PubMed]
    17. Kannel WB, Wolf PA, McGee DL, Dawber TR, McNamara P, Castelli WP. Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA. 1981;245((12)):1225–9. http://dx.doi.org/10.1001/jama.1981.03310370017013 [PubMed]
    18. Zanchetti A, Dampney RA, Ludbrook J, Mancia G, Stella A. Baroreceptor reflexes from different vascular areas in animals and man. Clin Sci Mol Med Suppl. 1976;3:339s–42s. http://dx.doi.org/10.1042/cs051339s [PubMed]
    19. Charkoudian N, Wallin BG. Sympathetic neural activity to the cardiovascular system: integrator of systemic physiology and interindividual characteristics. Compr Physiol. 2014;4((2)):825–50. http://dx.doi.org/10.1002/cphy.c130038 [PubMed]
    20. Hunt BE, Fahy L, Farquhar WB, Taylor JA. Quantification of mechanical and neural components of vagal baroreflex in humans. Hypertension. 2001;37((6)):1362–8. http://dx.doi.org/10.1161/01.HYP.37.6.1362 [PubMed]
    21. Abboud FM. The sympathetic system in hypertension. State-of-the-art review. Hypertension. 1982;4((3 Pt 2)):208–25. [PubMed]
    22. Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol. 2014;63((7)):636–46. http://dx.doi.org/10.1016/j.jacc.2013.09.063 [PMC free article] [PubMed]
    23. Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, et al. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens. 1998;16((12 Pt 2)):2079–84. http://dx.doi.org/10.1097/00004872-199816121-00033 [PubMed]
    2. Julius S. Effect of sympathetic overactivity on cardiovascular prognosis in hypertension. Eur Heart J. 1998;19((Suppl F)):F14–8. [PubMed]
    25. Barretto AC, Santos AC, Munhoz R, Rondon MU, Franco FG, Trombetta IC, et al. Increased muscle sympathetic nerve activity predicts mortality in heart failure patients. Int J Cardiol. 2009;135((3)):302–7. http://dx.doi.org/10.1016/j.ijcard.2008.03.056 [PubMed]
    26. Riebe D, Fernhall B, Thompson PD. The blood pressure response to exercise in anabolic steroid users. Med Sci Sports Exerc. 1992;24((6)):633–7. http://dx.doi.org/10.1249/00005768-199206000-00004 [PubMed]
    27. dos Santos MR, Dias RG, Laterza MC, Rondon MU, Braga AM, de Moraes Moreau RL, et al. Impaired post exercise heart rate recovery in anabolic steroid users. Int J Sports Med. 2013;34((10)):931–5. http://dx.doi.org/10.1055/s-0032-1331741 [PubMed]
    28. Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med. 1999;341((18)):1351–7. http://dx.doi.org/10.1056/NEJM199910283411804 [PubMed]
    29. Grassi G, Dell'Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens. 2004;22((12)):2363–9. http://dx.doi.org/10.1097/00004872-200412000-00019 [PubMed]
    30. Hartgens F, Van Marken Lichtenbelt WD, Ebbing S, Vollaard N, Rietjens G, Kuipers H. Body composition and anthropometry in bodybuilders: regional changes due to nandrolone decanoate administration. Int J Sports Med. 2001;22((3)):235–41. http://dx.doi.org/10.1055/s-2001-18679-1 [PubMed]

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2020